Glp-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis
[DOI] [PubMed] [Google Scholar] 81.Douglas CC, Gower BA, Darnell BE, Ovalle F, Oster RA, Azziz R
Keywords: airway inflammation, asthma, glucagon-like peptide-1 (GLP-1), interleukin-33 (IL-33), type 2 inflammation Introduction As one of the most prevalent chronic illnesses, asthma continues to have a significant global burden of disease, affecting over 25 million people in the US and as many as 330 million people worldwide [1]
Retatrutide is currently in Phase 3 clinical trials and is not yet FDA-approved
135 Small molecules The only small molecule GHR antagonist that has been reported is an orally available compound BVT-A (N-[5-(aminosulfonyl)-2-methylphenyl]-5-bromo-2-furamide)